SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,161,317 | -80.4% | 202,202 | -55.2% | 0.00% | -81.8% |
Q2 2023 | $21,218,810 | +12.8% | 451,272 | +0.7% | 0.02% | +10.0% |
Q1 2023 | $18,807,941 | -19.1% | 448,235 | -26.5% | 0.02% | -23.1% |
Q4 2022 | $23,244,385 | -17.7% | 609,449 | -15.5% | 0.03% | -23.5% |
Q3 2022 | $28,254,000 | +12.0% | 721,484 | -7.6% | 0.03% | +13.3% |
Q2 2022 | $25,216,000 | -19.5% | 780,685 | -17.5% | 0.03% | 0.0% |
Q1 2022 | $31,330,000 | -25.9% | 946,536 | -4.8% | 0.03% | -14.3% |
Q4 2021 | $42,296,000 | -24.0% | 994,269 | -20.9% | 0.04% | -30.0% |
Q3 2021 | $55,666,000 | -30.1% | 1,256,291 | -10.4% | 0.05% | -27.5% |
Q2 2021 | $79,656,000 | -43.1% | 1,402,143 | -25.1% | 0.07% | -48.9% |
Q1 2021 | $140,110,000 | -26.2% | 1,871,875 | -14.7% | 0.14% | -20.6% |
Q4 2020 | $189,880,000 | +26.1% | 2,194,887 | -10.9% | 0.17% | +10.4% |
Q3 2020 | $150,543,000 | +66.3% | 2,463,066 | +13.1% | 0.15% | +43.9% |
Q2 2020 | $90,526,000 | +662.8% | 2,177,156 | +426.9% | 0.11% | +463.2% |
Q1 2020 | $11,868,000 | -8.1% | 413,230 | +130.9% | 0.02% | +26.7% |
Q4 2019 | $12,921,000 | -55.3% | 178,993 | -13.1% | 0.02% | -58.3% |
Q3 2019 | $28,891,000 | +54.2% | 205,943 | +101.3% | 0.04% | +56.5% |
Q2 2019 | $18,730,000 | +15.1% | 102,300 | 0.0% | 0.02% | +9.5% |
Q1 2019 | $16,271,000 | +23.7% | 102,300 | -25.5% | 0.02% | +16.7% |
Q4 2018 | $13,152,000 | -20.7% | 137,300 | +17.0% | 0.02% | -5.3% |
Q3 2018 | $16,575,000 | -49.5% | 117,346 | -44.0% | 0.02% | -54.8% |
Q2 2018 | $32,825,000 | +206.3% | 209,709 | +215.1% | 0.04% | +200.0% |
Q1 2018 | $10,718,000 | -4.4% | 66,543 | -2.2% | 0.01% | -12.5% |
Q4 2017 | $11,207,000 | +499.6% | 68,043 | +126.8% | 0.02% | +433.3% |
Q3 2017 | $1,869,000 | -68.5% | 30,000 | -59.8% | 0.00% | -70.0% |
Q2 2017 | $5,941,000 | +163.6% | 74,597 | +135.2% | 0.01% | +150.0% |
Q1 2017 | $2,254,000 | +22.6% | 31,715 | -11.9% | 0.00% | +33.3% |
Q4 2016 | $1,838,000 | +32.9% | 36,000 | +19.9% | 0.00% | 0.0% |
Q3 2016 | $1,383,000 | +170.1% | 30,025 | +76.8% | 0.00% | +200.0% |
Q2 2016 | $512,000 | +49.3% | 16,978 | +188.8% | 0.00% | 0.0% |
Q4 2015 | $343,000 | – | 5,878 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |